Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment.
Sarabia De Ardanaz L, Andreu-Ubero JM, Navidad-Fuentes M, Ferrer-González MÁ, Ruíz Del Valle V, Salcedo-Bellido I, Barrios-Rodríguez R, Cáliz-Cáliz R, Requena P.
Sarabia De Ardanaz L, et al.
Front Pharmacol. 2021 Jul 1;12:620187. doi: 10.3389/fphar.2021.620187. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34276355
Free PMC article.